8 results
424B5
ACET
Adicet Bio Inc
11 Feb 21
Prospectus supplement for primary offering
5:20pm
approved CAR-T cell therapies.
S-8
Continue to innovate and invest in the gamma delta T cell platform and pipeline. We expect to continue
424B5
ACET
Adicet Bio Inc
10 Feb 21
Prospectus supplement for primary offering
12:00am
to innovate and invest in the gamma delta T cell platform and pipeline. We expect to continue to develop product candidates in oncology based
424B5
ot4n1z47jk03w
1 Dec 20
Prospectus supplement for primary offering
5:28pm
424B5
heug5v67f366
21 Sep 20
Prospectus supplement for primary offering
7:58am
8-K
EX-99.4
fqjcua9rjxjf
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
- Prev
- 1
- Next